STEVEN LEWIS
Yale professors shape New Haven biotech culture
The recent relocation of homegrown biopharma company Alexion to 100 College St. in New Haven, combined with the news that General Electric is moving its headquarters from Connecticut to Boston, highlights the paradigm shift from a reliance on larger Connecticut-based companies to a focus on smaller biopharma companies, according to molecular, cellular and developmental biology professor Craig Crews, who founded Proteolix and Arvinas, two biotech start-ups. In New Haven, health care innovation is driven by the interface between Yale professors and local biotech startups they found or guide through consultant and advising relationships.
April 1, 2016